Thymoma is associated with an increased risk of second malignancy

Chin Chen Pan, Paul Chih-HsuehChen, Liang Shun Wang, Kwan H. Chi, Hung Chiang

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

BACKGROUND. An association between thymoma and second malignancy has been suggested but has not been validated. Whether the relation is due to treatment or to other thymoma-associated conditions is unclear. METHODS. The authors studied 192 consecutive patients with thymoma and compared the incidence of second malignancies with those of 206 patients who underwent thymectomy for nonthymomatous conditions and 1426 patients with nasopharyngeal carcinoma (NPC). Detailed clinicopathologic features of thymoma patients with second malignancies were described. RESULTS. Additional malignancies were detected in 15 of 192 patients (8%) during their clinical courses. The risk for those patients was significantly greater compared with the risk for patients with nonthymomatous conditions (adjusted odds ratio [OR], 3.81; 95% confidential intervals [95%CI], 1.05-13.81; P = 0.042) and patients with NPC (adjusted OR, 4.89; 95%CI, 2.26-10.53; P <0.0001) after adjustment for age, gender, length of follow-up, myasthenia gravis, and radiation therapy. The occurrence of second malignancies did not correlate with histologic type or stage of thymoma, radiation therapy, or myasthenia gravis. CONCLUSIONS. Thymoma is associated with an increased risk of second malignancy. The association cannot be attributed to the effect of thymectomy or radiation therapy. Patients with thymoma, even if it is benign, should be followed regularly to facilitate the early detection of other malignancies.

Original languageEnglish
Pages (from-to)2406-2411
Number of pages6
JournalCancer
Volume92
Issue number9
DOIs
Publication statusPublished - Nov 1 2001
Externally publishedYes

Fingerprint

Thymoma
Second Primary Neoplasms
Thymectomy
Radiotherapy
Myasthenia Gravis
Odds Ratio
Neoplasms
Incidence

Keywords

  • Carcinoma
  • Myasthenia gravis
  • Radiation therapy
  • Thymectomy
  • Thymoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Pan, C. C., Chih-HsuehChen, P., Wang, L. S., Chi, K. H., & Chiang, H. (2001). Thymoma is associated with an increased risk of second malignancy. Cancer, 92(9), 2406-2411. https://doi.org/10.1002/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7

Thymoma is associated with an increased risk of second malignancy. / Pan, Chin Chen; Chih-HsuehChen, Paul; Wang, Liang Shun; Chi, Kwan H.; Chiang, Hung.

In: Cancer, Vol. 92, No. 9, 01.11.2001, p. 2406-2411.

Research output: Contribution to journalArticle

Pan, CC, Chih-HsuehChen, P, Wang, LS, Chi, KH & Chiang, H 2001, 'Thymoma is associated with an increased risk of second malignancy', Cancer, vol. 92, no. 9, pp. 2406-2411. https://doi.org/10.1002/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7
Pan, Chin Chen ; Chih-HsuehChen, Paul ; Wang, Liang Shun ; Chi, Kwan H. ; Chiang, Hung. / Thymoma is associated with an increased risk of second malignancy. In: Cancer. 2001 ; Vol. 92, No. 9. pp. 2406-2411.
@article{c919b9c027b14c27babc555998d409fe,
title = "Thymoma is associated with an increased risk of second malignancy",
abstract = "BACKGROUND. An association between thymoma and second malignancy has been suggested but has not been validated. Whether the relation is due to treatment or to other thymoma-associated conditions is unclear. METHODS. The authors studied 192 consecutive patients with thymoma and compared the incidence of second malignancies with those of 206 patients who underwent thymectomy for nonthymomatous conditions and 1426 patients with nasopharyngeal carcinoma (NPC). Detailed clinicopathologic features of thymoma patients with second malignancies were described. RESULTS. Additional malignancies were detected in 15 of 192 patients (8{\%}) during their clinical courses. The risk for those patients was significantly greater compared with the risk for patients with nonthymomatous conditions (adjusted odds ratio [OR], 3.81; 95{\%} confidential intervals [95{\%}CI], 1.05-13.81; P = 0.042) and patients with NPC (adjusted OR, 4.89; 95{\%}CI, 2.26-10.53; P <0.0001) after adjustment for age, gender, length of follow-up, myasthenia gravis, and radiation therapy. The occurrence of second malignancies did not correlate with histologic type or stage of thymoma, radiation therapy, or myasthenia gravis. CONCLUSIONS. Thymoma is associated with an increased risk of second malignancy. The association cannot be attributed to the effect of thymectomy or radiation therapy. Patients with thymoma, even if it is benign, should be followed regularly to facilitate the early detection of other malignancies.",
keywords = "Carcinoma, Myasthenia gravis, Radiation therapy, Thymectomy, Thymoma",
author = "Pan, {Chin Chen} and Paul Chih-HsuehChen and Wang, {Liang Shun} and Chi, {Kwan H.} and Hung Chiang",
year = "2001",
month = "11",
day = "1",
doi = "10.1002/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7",
language = "English",
volume = "92",
pages = "2406--2411",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Thymoma is associated with an increased risk of second malignancy

AU - Pan, Chin Chen

AU - Chih-HsuehChen, Paul

AU - Wang, Liang Shun

AU - Chi, Kwan H.

AU - Chiang, Hung

PY - 2001/11/1

Y1 - 2001/11/1

N2 - BACKGROUND. An association between thymoma and second malignancy has been suggested but has not been validated. Whether the relation is due to treatment or to other thymoma-associated conditions is unclear. METHODS. The authors studied 192 consecutive patients with thymoma and compared the incidence of second malignancies with those of 206 patients who underwent thymectomy for nonthymomatous conditions and 1426 patients with nasopharyngeal carcinoma (NPC). Detailed clinicopathologic features of thymoma patients with second malignancies were described. RESULTS. Additional malignancies were detected in 15 of 192 patients (8%) during their clinical courses. The risk for those patients was significantly greater compared with the risk for patients with nonthymomatous conditions (adjusted odds ratio [OR], 3.81; 95% confidential intervals [95%CI], 1.05-13.81; P = 0.042) and patients with NPC (adjusted OR, 4.89; 95%CI, 2.26-10.53; P <0.0001) after adjustment for age, gender, length of follow-up, myasthenia gravis, and radiation therapy. The occurrence of second malignancies did not correlate with histologic type or stage of thymoma, radiation therapy, or myasthenia gravis. CONCLUSIONS. Thymoma is associated with an increased risk of second malignancy. The association cannot be attributed to the effect of thymectomy or radiation therapy. Patients with thymoma, even if it is benign, should be followed regularly to facilitate the early detection of other malignancies.

AB - BACKGROUND. An association between thymoma and second malignancy has been suggested but has not been validated. Whether the relation is due to treatment or to other thymoma-associated conditions is unclear. METHODS. The authors studied 192 consecutive patients with thymoma and compared the incidence of second malignancies with those of 206 patients who underwent thymectomy for nonthymomatous conditions and 1426 patients with nasopharyngeal carcinoma (NPC). Detailed clinicopathologic features of thymoma patients with second malignancies were described. RESULTS. Additional malignancies were detected in 15 of 192 patients (8%) during their clinical courses. The risk for those patients was significantly greater compared with the risk for patients with nonthymomatous conditions (adjusted odds ratio [OR], 3.81; 95% confidential intervals [95%CI], 1.05-13.81; P = 0.042) and patients with NPC (adjusted OR, 4.89; 95%CI, 2.26-10.53; P <0.0001) after adjustment for age, gender, length of follow-up, myasthenia gravis, and radiation therapy. The occurrence of second malignancies did not correlate with histologic type or stage of thymoma, radiation therapy, or myasthenia gravis. CONCLUSIONS. Thymoma is associated with an increased risk of second malignancy. The association cannot be attributed to the effect of thymectomy or radiation therapy. Patients with thymoma, even if it is benign, should be followed regularly to facilitate the early detection of other malignancies.

KW - Carcinoma

KW - Myasthenia gravis

KW - Radiation therapy

KW - Thymectomy

KW - Thymoma

UR - http://www.scopus.com/inward/record.url?scp=0035498547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035498547&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7

DO - 10.1002/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7

M3 - Article

VL - 92

SP - 2406

EP - 2411

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 9

ER -